Literature DB >> 30370315

Proton Relative Biological Effectiveness - Uncertainties and Opportunities.

Harald Paganetti1.   

Abstract

Proton therapy treatments are prescribed using a biological effectiveness relative to photon therapy of 1.1, that is, proton beams are considered to be 10% more biologically effective. Debate is ongoing as to whether this practice needs to be revised. This short review summarizes current knowledge on relative biological effectiveness variations and uncertainties in vitro and in vivo. Clinical relevance is discussed and strategies toward biologically guided treatment planning are presented.

Entities:  

Keywords:  proton dose response; proton therapy; relative biological effectiveness

Year:  2018        PMID: 30370315      PMCID: PMC6200410          DOI: 10.14338/IJPT-18-00011.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  84 in total

1.  Inactivation of V79 cells by low-energy protons, deuterons and helium-3 ions.

Authors:  M Folkard; K M Prise; B Vojnovic; H C Newman; M J Roper; B D Michael
Journal:  Int J Radiat Biol       Date:  1996-06       Impact factor: 2.694

Review 2.  Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2014-10-31       Impact factor: 3.609

3.  Track structure analysis of ultrasoft X-rays compared to high- and low-LET radiations.

Authors:  D T Goodhead; H Nikjoo
Journal:  Int J Radiat Biol       Date:  1989-04       Impact factor: 2.694

4.  In vivo determinations of RBE in a high energy modulated proton beam using normal tissue reactions and fractionated dose schedules.

Authors:  J Tepper; L Verhey; M Goitein; H D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Nov-Dec       Impact factor: 7.038

Review 5.  Initial events in the cellular effects of ionizing radiations: clustered damage in DNA.

Authors:  D T Goodhead
Journal:  Int J Radiat Biol       Date:  1994-01       Impact factor: 2.694

6.  The relative biological effectiveness of 138-Mev protons as compared to cobalt-60 gamma radiation.

Authors:  G V Dalrymple; I R Lindsay; J D Hall; J C Mitchell; J J Ghidoni; H L Kundel; I L Morgan
Journal:  Radiat Res       Date:  1966-06       Impact factor: 2.841

7.  The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer.

Authors:  N Tilly; J Johansson; U Isacsson; J Medin; E Blomquist; E Grusell; B Glimelius
Journal:  Phys Med Biol       Date:  2005-05-25       Impact factor: 3.609

8.  Cellular radiosensitivity and complication risk after curative radiotherapy.

Authors:  J Peacock; A Ashton; J Bliss; C Bush; J Eady; C Jackson; R Owen; J Regan; J Yarnold
Journal:  Radiother Oncol       Date:  2000-05       Impact factor: 6.280

9.  Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization.

Authors:  A F Resch; G Landry; F Kamp; G Cabal; C Belka; J J Wilkens; K Parodi; G Dedes
Journal:  Phys Med       Date:  2017-03-30       Impact factor: 2.685

10.  Biological effects of passive versus active scanning proton beams on human lung epithelial cells.

Authors:  Daila S Gridley; Michael J Pecaut; Xiao W Mao; Andrew J Wroe; Xian Luo-Owen
Journal:  Technol Cancer Res Treat       Date:  2014-11-11
View more
  14 in total

Review 1.  Proton RBE dependence on dose in the setting of hypofractionation.

Authors:  Thomas Friedrich
Journal:  Br J Radiol       Date:  2019-08-28       Impact factor: 3.039

Review 2.  Treatment planning for proton therapy: what is needed in the next 10 years?

Authors:  Hakan Nystrom; Maria Fuglsang Jensen; Petra Witt Nystrom
Journal:  Br J Radiol       Date:  2019-08-07       Impact factor: 3.039

Review 3.  Modelling variable proton relative biological effectiveness for treatment planning.

Authors:  Aimee McNamara; Henning Willers; Harald Paganetti
Journal:  Br J Radiol       Date:  2019-11-18       Impact factor: 3.039

Review 4.  Proton beam therapy: perspectives on the National Health Service England clinical service and research programme.

Authors:  Neil G Burnet; Ranald I Mackay; Ed Smith; Amy L Chadwick; Gillian A Whitfield; David J Thomson; Matthew Lowe; Norman F Kirkby; Adrian M Crellin; Karen J Kirkby
Journal:  Br J Radiol       Date:  2020-01-14       Impact factor: 3.039

Review 5.  Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists.

Authors:  Alice Y Ho; Jean L Wright; Rachel C Blitzblau; Robert W Mutter; Dan G Duda; Larry Norton; Aditya Bardia; Laura Spring; Steven J Isakoff; Jonathan H Chen; Clemens Grassberger; Jennifer R Bellon; Sushil Beriwal; Atif J Khan; Corey Speers; Samantha A Dunn; Alastair Thompson; Cesar A Santa-Maria; Ian E Krop; Elizabeth Mittendorf; Tari A King; Gaorav P Gupta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-05-14       Impact factor: 7.038

6.  Overcoming radioresistance in WiDr cells with heavy ion irradiation and radiosensitization by 2-deoxyglucose with photon irradiation.

Authors:  Felix Christian Hasse; Stefan Alexander Koerber; Elena Sophie Prigge; Jakob Liermann; Magnus von Knebel Doeberitz; Juergen Debus; Florian Sterzing
Journal:  Clin Transl Radiat Oncol       Date:  2019-08-20

Review 7.  Ionizing Radiation and Complex DNA Damage: From Prediction to Detection Challenges and Biological Significance.

Authors:  Ifigeneia V Mavragani; Zacharenia Nikitaki; Spyridon A Kalospyros; Alexandros G Georgakilas
Journal:  Cancers (Basel)       Date:  2019-11-14       Impact factor: 6.639

Review 8.  Hadrontherapy Interactions in Molecular and Cellular Biology.

Authors:  Juliette Thariat; Samuel Valable; Carine Laurent; Siamak Haghdoost; Elodie A Pérès; Myriam Bernaudin; François Sichel; Paul Lesueur; Mathieu Césaire; Edwige Petit; Aurélie E Ferré; Yannick Saintigny; Sven Skog; Mihaela Tudor; Michael Gérard; Sebastien Thureau; Jean-Louis Habrand; Jacques Balosso; François Chevalier
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

9.  Prospective Assessment of Early Proton Therapy-Induced Optic Neuropathy in Patients With Intracranial, Orbital or Sinonasal Tumors: Impact of A Standardized Ophthalmological Follow Up.

Authors:  Marie Lecornu; Paul Lesueur; Julia Salleron; Jacques Balosso; Dinu Stefan; William Kao; Tiphaine Plouhinec; Anthony Vela; Pauline Dutheil; Jordan Bouter; Pierre-Alban Marty; Juliette Thariat; Jean-Claude Quintyn
Journal:  Front Oncol       Date:  2021-06-15       Impact factor: 6.244

10.  Postsurgical geometrical variations of tumor bed and brainstem during photon and proton therapy for pediatric tumors of the posterior fossa: dosimetric impact and predictive factors.

Authors:  Stefania Volpe; Pierre-Yves Bondiau; Line Claude; Audrey Claren; Laetitia Padovani; Hamza AlGhamdi; Gwenaëlle Duhil De Benaze; Lucas Opitz; Guillaume Baudin; Catherine Dejean; Daniel Maneval; Barbara Alicja Jereczek-Fossa; Jérôme Doyen
Journal:  Strahlenther Onkol       Date:  2021-08-05       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.